Recombinant Hydrurga leptonyx NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Shipped with Ice Packs
In Stock

Description

Clinical and Therapeutic Significance

MT-ND4L mutations are linked to mitochondrial disorders:

ConditionMechanismKey Mutation
Leber Hereditary Optic Neuropathy (LHON)Disrupted Complex I function, impairing ATP production in optic nerves .T10663C (Val65Ala) .
Metabolic DisordersAssociated with increased BMI, obesity, and hypertension .Polymorphisms in MT-ND4L .

AI-Driven Research Insights:

  • Targeted Therapies: Receptor.AI’s AI models predict binding pockets and screen small-molecule ligands for LHON treatment .

  • Conformational Dynamics: AI simulations reveal functional states of MT-ND4L, aiding drug design .

  • Focused Libraries: Reaxense-developed libraries prioritize compounds with favorable ADME-Tox profiles .

Research and Development Advancements

Key Findings:

  1. Gene Overlap: The MT-ND4L gene overlaps with MT-ND4, enabling efficient transcription of adjacent subunits .

  2. Electron Transport: MT-ND4L stabilizes the hydrophobic core of Complex I, ensuring proper electron transfer and proton pumping .

  3. Therapeutic Potential: AI-driven virtual screening identifies novel ligands targeting MT-ND4L for LHON and metabolic diseases .

Challenges:

  • Limited structural data on recombinant MT-ND4L from Hydrurga leptonyx.

  • Molecular weight and formula remain undetermined in available sources .

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them during order placement. We will fulfill your request whenever possible.
Lead Time
Delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery times.
Note: Our proteins are standardly shipped with normal blue ice packs. If you require dry ice shipping, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by several factors, including storage conditions, buffer ingredients, storage temperature, and the protein's inherent stability.
Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
MT-ND4L; MTND4L; NADH4L; ND4L; NADH-ubiquinone oxidoreductase chain 4L; NADH dehydrogenase subunit 4L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-98
Protein Length
full length protein
Species
Hydrurga leptonyx (Leopard seal) (Phoca leptonyx)
Target Names
Target Protein Sequence
MTMVYANIFLAFITSLMGLLMYRSHLMSSLLCLEGMMLSLFVMMTVTILNNHFTLASMTP IILLVFAACEAALGLSLLVMVSNTYGTDYVQNLNLLQC
Uniprot No.

Target Background

Function
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). This protein catalyzes electron transfer from NADH through the respiratory chain, utilizing ubiquinone as an electron acceptor.
Protein Families
Complex I subunit 4L family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is MT-ND4L and what is its role in mitochondrial function?

MT-ND4L (mitochondrially encoded NADH dehydrogenase 4L) is a protein subunit of Complex I (NADH-ubiquinone oxidoreductase) in the mitochondrial respiratory chain. It plays a critical role in the first step of electron transport during oxidative phosphorylation, where it helps transfer electrons from NADH to ubiquinone. This process creates an electrochemical gradient across the inner mitochondrial membrane that drives ATP synthesis .

The protein is encoded by the mitochondrial genome, specifically by the MT-ND4L gene, and is embedded in the inner mitochondrial membrane as a multi-pass membrane protein . In Hydrurga leptonyx (Leopard seal), as in other mammals, this protein contributes to the proton-pumping function of Complex I, which is essential for cellular energy production.

How can recombinant Hydrurga leptonyx MT-ND4L be produced and purified for experimental use?

Production of recombinant Hydrurga leptonyx MT-ND4L typically involves:

  • Gene synthesis and vector cloning: The MT-ND4L gene sequence is synthesized based on the known sequence and optimized for expression in the chosen host system (typically E. coli, yeast, or mammalian cells).

  • Expression optimization: Due to its hydrophobic nature, expression conditions must be carefully optimized, often using specialized host strains and fusion tags (such as His-tag, GST, or MBP) to enhance solubility.

  • Purification protocol:

    • Cell lysis using detergents suitable for membrane proteins

    • Immobilized metal affinity chromatography (if His-tagged)

    • Size exclusion chromatography for further purification

    • Detergent exchange to stabilize the protein in solution

  • Quality control:

    • SDS-PAGE to confirm molecular weight (approximately 10.7 kDa)

    • Western blot using anti-MT-ND4L antibodies

    • Mass spectrometry for sequence verification

The purified recombinant protein is typically stored in a detergent-containing buffer with 50% glycerol at -20°C or -80°C to maintain stability .

What methods are effective for quantifying Complex I content and enzymatic activity when studying MT-ND4L function?

Quantification of Complex I content and activity requires specialized techniques:

For Complex I content measurement:

  • Native polyacrylamide gel electrophoresis (hrCN-PAGE) combined with flavin fluorescence scanning provides an absolute quantification method for Complex I.

  • The technique exploits the intrinsic fluorescence of FMN bound to the 51 kDa (NDUFV1) subunit of Complex I.

For enzymatic activity measurement:

  • NADH:ubiquinone oxidoreductase activity assay - measures the rate of NADH oxidation in the presence of ubiquinone (Q1) as an electron acceptor.

  • NADH:HAR (hexaammineruthenium) activity assay - an alternative assay that measures the NADH dehydrogenase activity independently of the ubiquinone binding site.

A comprehensive study by researchers demonstrated that Complex I content varies significantly among tissues, with brain mitochondria containing approximately 19 ± 1 pmol/mg of protein. The catalytic turnover (kcat) can be calculated by dividing the specific activity by the enzyme content, with values reported around 10^4 min^-1 for physiological substrates .

Tissue/SampleComplex I content (pmol/mg protein)NADH:HAR activityNADH:Q1 activitykcat (min^-1)
Mouse brain mitochondria19 ± 14.5 ± 0.30.8 ± 0.14.2 × 10^4
HEK293 cells0.152 ± 0.003 pmol/10^6 cells---

These methods allow researchers to accurately determine both the amount and specific activity of Complex I containing MT-ND4L in experimental samples .

How can researchers distinguish between superoxide production sites within Complex I when studying MT-ND4L mutations?

Researchers can distinguish between different superoxide production sites within Complex I using a methodical approach:

  • Experimental design for site identification:

    • Use a sucrose-based assay medium (rather than KCl-based) to ensure stable and linear rates of superoxide production.

    • Apply rotenone (4 μM) to specifically inhibit electron transport at the Q-binding site of Complex I.

    • Compare forward versus reverse electron transport conditions to differentiate between sites.

    • Manipulate the redox state of NAD(P)H and the Q pool independently.

  • Site differentiation approach:

    • Site IF (flavin site): Superoxide production is primarily dependent on the NADH/NAD+ ratio, maximizing when NAD pool is highly reduced during forward electron transport.

    • Site IQ (Q-binding site): Superoxide production responds to both Q pool redox state and protonmotive force, particularly during reverse electron transport.

The two-site model is supported by experiments showing that:

  • During reverse electron transport, rotenone-sensitive superoxide production depends on protonmotive force generated by ATP hydrolysis.

  • Atpenin A5 (a complex II Q site inhibitor) inhibits superoxide production similar to rotenone.

  • Superoxide production during reverse electron transport is not uniquely related to NAD reduction state .

This methodology is particularly valuable when evaluating how MT-ND4L mutations might differentially affect superoxide production at these distinct sites, providing insights into potential mechanisms of mitochondrial dysfunction.

What approaches can be used to evaluate the impact of MT-ND4L variants on mitochondrial function in living systems?

To evaluate the functional impact of MT-ND4L variants in living systems, researchers can employ the following approaches:

  • Conplastic strain development:

    • Generate conplastic strains by transferring mitochondrial DNA (mtDNA) containing the variant of interest onto a consistent nuclear genetic background.

    • This approach allows for direct attribution of phenotypic differences to specific mtDNA variations.

    • Example: The SHR-mtLEW conplastic rat strain was developed to study the effects of variants in mt-Nd2, mt-Nd4, and mt-Nd5 genes by transferring the LEW mitochondrial genome onto the SHR nuclear background .

  • Comprehensive functional assessment:

    • Measure oxidative and non-oxidative glucose metabolism in tissues (particularly skeletal muscle).

    • Assess insulin-stimulated glucose incorporation into lipids.

    • Analyze serum non-esterified fatty acid levels.

    • Evaluate mitochondrial enzyme activities.

  • Genetic verification:

    • Confirm nuclear genome homozygosity using polymorphic markers spaced at ~10 cM intervals.

    • Perform complete mtDNA sequencing to verify the presence of only the variants of interest.

In a study comparing SHR and SHR-mtLEW conplastic rats, researchers found that specific variants in mt-Nd2, mt-Nd4, and mt-Nd5 genes were linked to significant metabolic differences, including reduced oxidative and non-oxidative glucose metabolism in skeletal muscle and resistance to insulin-stimulated incorporation of glucose into adipose tissue lipids . This demonstrates how conplastic models can isolate the effects of specific mitochondrial gene variants in a living system.

How does MT-ND4L structure and function compare between Hydrurga leptonyx and other mammals?

The MT-ND4L protein shows both conservation and variation across mammalian species, reflecting its essential function and evolutionary adaptation:

  • Sequence conservation:

    • The core functional domains of MT-ND4L tend to be highly conserved across mammalian species, particularly in regions critical for electron transport.

    • Transmembrane domains show higher conservation than loop regions.

  • Species-specific variations:

    • Certain amino acid positions show species-specific variations that may reflect adaptation to different metabolic demands or environmental conditions.

    • For example, the SHR strain has a Thr356 variant that appears unique compared to other species including human, bovine, dog, and fugu fish, which all have alanine at this position .

  • Functional implications:

    • Variations near the ubiquinone binding site may affect electron transfer efficiency.

    • Changes in transmembrane domains could influence proton pumping capacity.

    • Some variations may affect interaction with nuclear-encoded subunits of Complex I.

Comparative analysis suggests that while the core function of MT-ND4L is preserved across species, subtle variations may contribute to differences in metabolic efficiency, adaptability to different energy demands, and potentially resistance to certain stressors or environmental conditions. The study of Hydrurga leptonyx MT-ND4L may provide insights into adaptations specific to marine mammals living in cold environments with specialized metabolic demands.

What non-invasive methods can be used to study MT-ND4L variations in protected marine mammals like Hydrurga leptonyx?

For protected marine mammals like the leopard seal (Hydrurga leptonyx), non-invasive methods for studying MT-ND4L variations include:

  • Fecal sample collection and analysis:

    • Feces can be collected from haul-out sites without disturbing the animals.

    • Optimized methods for DNA extraction from fecal samples can yield host mitochondrial DNA for analysis.

    • Collection techniques include swabbing the fecal surface or processing the inner core of fecal material.

  • DNA amplification from fecal samples:

    • PCR optimization for mitochondrial gene amplification:

      • Nested PCR approaches can improve specificity when working with degraded DNA.

      • Target the mitochondrial control region initially, then specific genes like MT-ND4L.

    • Real-time PCR methods can provide higher sensitivity for detecting low-copy-number DNA.

  • Environmental DNA (eDNA) analysis:

    • Water samples from areas frequented by the species can contain sloughed cells.

    • Advanced DNA capture and enrichment techniques can be used to isolate mitochondrial DNA sequences from environmental samples.

Research on Juan Fernandez fur seals demonstrated that with optimized methods, fecal samples can provide valuable genetic information for population studies while avoiding the need for invasive sampling . Similar approaches could be applied to study MT-ND4L variations in leopard seals, particularly in the context of understanding metabolic adaptations and potential implications for conservation.

What is the evidence linking MT-ND4L mutations to Leber hereditary optic neuropathy and other mitochondrial diseases?

MT-ND4L mutations have been implicated in several mitochondrial disorders, with the strongest evidence for Leber hereditary optic neuropathy (LHON):

  • LHON-associated MT-ND4L mutation:

    • A specific mutation in the MT-ND4L gene (T10663C or Val65Ala) has been identified in several families with LHON.

    • This mutation changes a single amino acid, replacing valine with alanine at position 65 of the NADH dehydrogenase 4L protein .

  • Pathological mechanisms:

    • Complex I dysfunction: Mutations in MT-ND4L can impair the structure and function of Complex I, reducing ATP production.

    • Increased reactive oxygen species (ROS): Dysfunctional Complex I may increase superoxide production, particularly at sites IF and IQ.

    • Tissue specificity: The high energy demands of retinal ganglion cells make them particularly vulnerable to Complex I defects.

  • Other disease associations:

    • Some MT-ND4L variants have been implicated in diabetes mellitus, particularly when occurring close to known pathological mutations.

    • Variants in MT-ND4L may also contribute to exercise intolerance and other manifestations of mitochondrial dysfunction .

While the exact mechanism by which the Val65Ala mutation leads to the specific pattern of vision loss in LHON remains incompletely understood, the association suggests that this position in MT-ND4L is critical for proper Complex I function in retinal ganglion cells.

How can researchers experimentally determine the pathogenicity of novel MT-ND4L variants?

Determining the pathogenicity of novel MT-ND4L variants requires a multi-faceted experimental approach:

  • In vitro functional assessment:

    • Construct cybrid cell lines by transferring mitochondria containing the variant into mtDNA-depleted cells (ρ⁰ cells).

    • Measure Complex I assembly and activity using techniques like BN-PAGE and spectrophotometric assays.

    • Assess mitochondrial membrane potential using fluorescent probes (TMRM, JC-1).

    • Quantify ROS production using specific probes (MitoSOX for superoxide).

    • Evaluate ATP synthesis rate and oxygen consumption (using Seahorse analyzer).

  • Structural impact prediction:

    • Use site-directed mutagenesis to introduce the variant into recombinant MT-ND4L.

    • Perform protein structural analysis to determine effects on protein folding and stability.

    • Assess the impact on interactions with other Complex I subunits.

  • In vivo models:

    • Generate conplastic animal models where the variant is the only mtDNA difference.

    • Comprehensively phenotype these models for:

      • Tissue-specific Complex I activity

      • Metabolic parameters (glucose handling, insulin sensitivity)

      • Tissue-specific manifestations (e.g., retinal ganglion cell function for LHON-related variants)

  • Clinical correlation:

    • Compare functional data with clinical phenotypes in patients harboring the variant.

    • Consider heteroplasmy levels (percentage of mutant mtDNA) in affected tissues.

    • Evaluate family history and segregation of the variant with disease phenotype.

This systematic approach allows researchers to establish causal relationships between MT-ND4L variants and disease phenotypes, providing insights into both pathogenic mechanisms and potential therapeutic targets.

What strategies can be employed to investigate the role of MT-ND4L in superoxide production and mitochondrial ROS signaling?

Advanced investigation of MT-ND4L's role in superoxide production and ROS signaling requires sophisticated experimental approaches:

  • Site-specific superoxide measurement:

    • Utilize genetically-encoded, mitochondrially-targeted superoxide sensors (e.g., MitoSOX, mitoHyPer) with high spatial and temporal resolution.

    • Combine with targeted mutations in MT-ND4L that affect specific electron transfer sites.

    • Implement pulse-chase experiments with isotope-labeled substrates to track electron flow through Complex I.

  • Structure-function analysis:

    • Generate point mutations at conserved residues in MT-ND4L to identify amino acids critical for superoxide formation.

    • Correlate structural changes (using cryo-EM) with alterations in superoxide production patterns.

    • Employ molecular dynamics simulations to predict how specific residues influence electron leakage.

  • Redox regulation mapping:

    • Identify redox-sensitive thiols in MT-ND4L that may function as regulatory switches.

    • Map the interaction between MT-ND4L redox state and post-translational modifications of Complex I subunits.

    • Investigate how altered MT-ND4L function affects mitochondrial retrograde signaling to the nucleus.

  • Experimental design principles:

    • Control for both NAD pool redox state and Q pool redox state independently.

    • Differentiate between superoxide production during forward vs. reverse electron transport.

    • Consider the influences of membrane potential, pH gradient, and substrate availability.

The two-site model (site IF at the flavin and site IQ at the Q-binding site) provides a framework for understanding how MT-ND4L may influence site-specific superoxide production. Research has shown that site IQ-derived superoxide during reverse electron transport is sensitive to the Q pool redox state and dependent on protonmotive force, while site IF superoxide production is primarily influenced by NADH/NAD+ ratio .

How might comparative analysis of MT-ND4L across marine mammals provide insights into metabolic adaptations to extreme environments?

Comparative analysis of MT-ND4L across marine mammals offers unique insights into metabolic adaptations to extreme environments:

  • Adaptive evolution analysis:

    • Calculate selection pressures (dN/dS ratios) on MT-ND4L sequences across marine mammal lineages.

    • Identify convergent amino acid changes in species adapted to similar environmental challenges (deep diving, cold water, etc.).

    • Correlate specific amino acid substitutions with physiological traits (diving capacity, thermogenesis).

  • Functional genomics approach:

    • Express recombinant MT-ND4L variants from different marine mammals in standardized cellular systems.

    • Compare:

      • Complex I activity at different temperatures

      • ROS production under hypoxic conditions

      • Efficiency of electron transfer under various pressures

    • Assess protein stability and assembly into Complex I under conditions mimicking deep diving.

  • Integrated physiological context:

    • Correlate MT-ND4L variations with:

      • Mitochondrial density in different tissues

      • Myoglobin concentration (oxygen storage)

      • Antioxidant defense mechanisms

  • Conservation implications:

    • Assess genetic diversity of MT-ND4L within endangered marine mammal populations.

    • Evaluate potential vulnerability to environmental changes based on metabolic adaptations.

    • Develop non-invasive monitoring techniques using environmental DNA or fecal samples.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.